Jane Street
LUCD icon

Jane Street’s Lucid Diagnostics LUCD Stock Holding History

Jane Street’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-362,615
Closed -$395K – 12393
2025
Q4 		$395K Buy
362,615
+332,975
+1,123% +$372K ﹤0.01% 8212
2025
Q3 		$29.9K Buy
+29,640
New +$32.4K ﹤0.01% 10460
2025
Q1 		– Sell
-13,819
Closed -$11.3K – 10118
2024
Q4 		$11.3K Buy
13,819
+2,848
+26% +$2.51K ﹤0.01% 9173
2024
Q3 		$8.94K Buy
+10,971
New +$8.98K ﹤0.01% 9363
2024
Q2 		– Sell
-122,013
Closed -$98.8K – 9851
2024
Q1 		$98.8K Buy
122,013
+109,668
+888% +$142K ﹤0.01% 8530
2023
Q4 		$17.4K Sell
12,345
-4,977
-29% -$6.56K ﹤0.01% 8925
2023
Q3 		$20.3K Buy
+17,322
New +$25.1K ﹤0.01% 8305
2022
Q4 		– Sell
-15,602
Closed -$24K – 9706
2022
Q3 		$24K Buy
+15,602
New +$38.8K ﹤0.01% 9152

Other funds holding LUCD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Jane Street's LUCD Position: Q1 2026 in Review

Jane Street sold out of Lucid Diagnostics (LUCD) in Q1 2026, closing a stake of 362,615 shares — an estimated $395K sold.

Jane Street first reported a position in LUCD in Q3 2022 and held it in 8 quarters. The position peaked at $395K in Q4 2025. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Jane Street reported no remaining Lucid Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 362,615 Lucid Diagnostics shares in Q1 2026, an estimated $395K.
  • Jane Street first reported a position in Lucid Diagnostics in Q3 2022 and held it in 8 quarters.
  • Jane Street's Lucid Diagnostics position peaked at $395K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.